Tags: twitter | jpmorgan | goldman | musk takeover bid | poison pill

Twitter Hires JPMorgan, Goldman as Advisors on Musk Takeover


By    |   Friday, 15 April 2022 03:05 PM EDT

Twitter has hired investment banking firms JPMorgan and Goldman Sachs in response to Elon Musk's hostile takeover bid, Bloomberg reports, citing people familiar with the matter.

Twitter had already hired JPMorgan, the biggest bank in the U.S., to help it find potential buyers, the sources said, asking to remain anonymous.

Media representatives from Twitter and JPMorgan declined to comment for Bloomberg.

Thoma Bravo, a technology-focused private equity firm that had more than $103 billion in assets under management as of the end of December, has informed Twitter that it is exploring the possibility of putting together a bid, people familiar with the matter told Thomson Reuters.

It is not clear how much Thoma Bravo would be prepared to offer, and there is no certainty that such a rival bid will materialize, the sources cautioned, also asking not to be identified because the matter is confidential.

A Thoma Bravo spokesperson declined to comment for Thomson Reuters, while Twitter representatives did not immediately respond to a request for comment. The New York Post reported on Thursday that Thoma Bravo was considering a bid for Twitter.

PE Firms Have $1.8T in 'Dry Powder'

The moves raise the specter of more private equity firms vying for Twitter. The global private equity industry is sitting on about $1.8 trillion in dry powder, according to data provider Preqin. Unlike major technology conglomerates, most buyout firms would not face antitrust restrictions in acquiring Twitter.

It remains possible that a private equity firm will boost Musk's bid by partnering with him rather than challenging him. Musk's criticism of Twitter's reliance on advertising for most of its revenue, however, has made some private equity firms apprehensive about teaming up with him, industry sources said. This is because a strong cash flow makes financing a leveraged buyout much easier.

Twitter has more than $6 billion of cash on its balance sheet and its annual cash flow is close to $700 million, providing some comfort to banks considering whether should provide debt for a deal. Still, a leveraged buyout for Twitter could be the biggest of all time, potentially requiring several buyout firms and other major institutional investors to team up.

Musk is the world's richest man with a net worth pegged by Forbes at $265 billion. He has, however, drawn a line on how much he is willing to pay. He informed Twitter on Wednesday that his $54.20-per-share all-cash bid for the company was his "best and final offer," and that he would reconsider his position as a Twitter shareholder if it was rejected. Musk owns more than 9% of Twitter, making him the largest shareholder after mutual fund giant Vanguard.

Musk tweeted on Thursday that Twitter's shareholders should have a say on his offer and posted a poll on Twitter in which most users agreed with him. Twitter's board is still assessing Musk's offer and would only put it to the company's shareholders for a vote if it approves it. Twitter shares fell on Thursday, indicating that most investors expect the company's board to reject Musk's bid as inadequate and thin on financing details.

Twitter's Poison Pill

Twitter said on Friday it adopted a poison pill that would dilute anyone amassing a stake in the company of more than 15% by selling more shares to other shareholders. Known formally as a shareholder rights plan, the poison pill will be in place for 364 days.

The move would not prevent Musk from taking his offer directly to Twitter shareholders by launching a tender offer. While the poison pill would prevent most Twitter shareholders from selling their shares, the tender offer would allow them to register their support or disapproval of Musk's offer. 


© 2024 Newsmax Finance. All rights reserved.

Twitter has hired investment banking firms JPMorgan and Goldman Sachs in response to Elon Musk's hostile takeover bid.
twitter, jpmorgan, goldman, musk takeover bid, poison pill
Friday, 15 April 2022 03:05 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
Get Newsmax Text Alerts

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved
© Newsmax Media, Inc.
All Rights Reserved